-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q3 2024.
- Estrella Immunopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$2.22M, a 706% decline year-over-year.
- Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$16.1M, a 1103% decline from 2023.
- Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.34M, a 28% decline from 2022.
- Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.04M, a 230% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)